Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity
- PMID: 7515183
- PMCID: PMC43903
- DOI: 10.1073/pnas.91.11.4930
Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity
Abstract
To investigate the mechanisms of T-cell-mediated cytotoxicity, we estimated the involvement of apoptosis-inducing Fas molecule on the target cells and its ligand on the effector cells. When redirected by ConA or anti-CD3 monoclonal antibody, a CD4+ T-cell clone, BK1, could lyse the target cells expressing wild-type Fas molecule but not those expressing death signaling-deficient mutants. This indicates the involvement of Fas-mediated signal transduction in the target cell lysis by BK1. Anti-CD3-activated but not resting BK1 expressed Fas ligand as detected by binding of a soluble Fas-Ig fusion protein, and the BK1-mediated cytotoxicity was blocked by the addition of Fas-Ig, implicating the inducible Fas ligand in the BK1 cytotoxicity. Ability to exert the Fas-mediated cytotoxicity was not confined to BK1, but splenic CD4+ T cells and, to a lesser extent, CD8+ T cells could also exert the Fas-dependent target cell lysis. This indicates that the Fas-mediated target cell lytic pathway can be generally involved in the T-cell-mediated cytotoxicity. Interestingly, CD4+ T cells prepared from gld/gld mice did not mediate the Fas-mediated cytotoxicity, indicating defective expression of functional Fas ligand in gld mice.
Similar articles
-
Participation of target Fas protein in apoptosis pathway induced by CD4+ Th1 and CD8+ cytotoxic T cells.Proc Natl Acad Sci U S A. 1994 May 10;91(10):4185-9. doi: 10.1073/pnas.91.10.4185. Proc Natl Acad Sci U S A. 1994. PMID: 7514297 Free PMC article.
-
Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity.J Immunol. 1994 Feb 1;152(3):1127-33. J Immunol. 1994. PMID: 7507960
-
TCR alpha/beta and TCR gamma/delta CD4-/CD8- HLA-DR alloreactive CTL clones do not use Fas/Fas ligand pathway to lyse their specific target cells.Hum Immunol. 1996 Nov;51(1):13-22. doi: 10.1016/s0198-8859(96)00164-4. Hum Immunol. 1996. PMID: 8911993
-
Fas and Fas ligand: lpr and gld mutations.Immunol Today. 1995 Jan;16(1):39-43. doi: 10.1016/0167-5699(95)80069-7. Immunol Today. 1995. PMID: 7533498 Review.
-
On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.Leuk Lymphoma. 1998 Nov;31(5-6):477-90. doi: 10.3109/10428199809057607. Leuk Lymphoma. 1998. PMID: 9922038 Review.
Cited by
-
Soluble Fas ligand inhibits angiogenesis in rheumatoid arthritis.Arthritis Res Ther. 2007;9(2):R42. doi: 10.1186/ar2181. Arthritis Res Ther. 2007. PMID: 17459170 Free PMC article.
-
Fas antigen expression and its relationship with apoptosis in human hepatocellular carcinoma and noncancerous tissues.Am J Pathol. 1996 Aug;149(2):429-37. Am J Pathol. 1996. PMID: 8701982 Free PMC article.
-
Effector CD4+ T-cell involvement in clearance of infectious herpes simplex virus type 1 from sensory ganglia and spinal cords.J Virol. 2008 Oct;82(19):9678-88. doi: 10.1128/JVI.01159-08. Epub 2008 Jul 30. J Virol. 2008. PMID: 18667492 Free PMC article.
-
Expression of the functional soluble form of human fas ligand in activated lymphocytes.EMBO J. 1995 Mar 15;14(6):1129-35. doi: 10.1002/j.1460-2075.1995.tb07096.x. EMBO J. 1995. PMID: 7536672 Free PMC article.
-
Peripheral T cells undergoing superantigen-induced apoptosis in vivo express B220 and upregulate Fas and Fas ligand.J Exp Med. 1996 Feb 1;183(2):431-7. doi: 10.1084/jem.183.2.431. J Exp Med. 1996. PMID: 8627156 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous